Evidence map›Paper›PMID 37104033›Full record

ArticleJCI insight2023

Spheroids as a model for endometriotic lesions.

Yong Song, Gregory W Burns, Niraj R Joshi, Ripla Arora, J Julie Kim, Asgerally T Fazleabas

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Building Disease Models for Endometriosis: iPSCs as Game-Changers.International journal of molecular sciences · 2026
    Review
  4. Article
  5. Exploring endometriosis through 3DMaterials today. Bio · 2026
    Review
  6. Article
  7. Cells · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Three-dimensional patient-derived endometriosis model for drug evaluation.Acta obstetricia et gynecologica Scandinavica · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Modelling Endometriosis Using In Vitro and In Vivo Systems.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yong SongDepartment of Obstetrics, Gynecology and Reproductive Biology, Michigan State University, Grand Rapids, Michigan, USA.
Gregory W BurnsDepartment of Obstetrics, Gynecology and Reproductive Biology, Michigan State University, Grand Rapids, Michigan, USA.
Niraj R JoshiDepartment of Obstetrics, Gynecology and Reproductive Biology, Michigan State University, Grand Rapids, Michigan, USA.
Ripla AroraDepartment of Obstetrics, Gynecology and Reproductive Biology, Michigan State University, Grand Rapids, Michigan, USA.
J Julie KimDepartment of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Asgerally T FazleabasDepartment of Obstetrics, Gynecology and Reproductive Biology, Michigan State University, Grand Rapids, Michigan, USA.
Michigan State University · USNorthwestern University · US

Funding

Regulation of Endometriotic Lesion Development by NOTCH1R01HD099090 · NICHD · MICHIGAN STATE UNIVERSITY · PI FAZLEABAS, ASGERALLY T. · 2021 to 2025
$2.8M
Reproductive and Developmental Sciences Training Program - T32T32HD087166 · NICHD · MICHIGAN STATE UNIVERSITY · PI Ronald L Chandler, Keith E Latham · 2016 to 2026
$2.5M
Signaling mechanisms that modulate uterine 3D structure for pregnancy successR01HD109152 · NICHD · MICHIGAN STATE UNIVERSITY · PI Ripla Arora · 2022 to 2026
$2.0M
Role of microRNA in the Pathophysiology of EndometriosisR01HD083273 · NICHD · MICHIGAN STATE UNIVERSITY · PI FAZLEABAS, ASGERALLY T. · 2016 to 2020
$1.8M
Biological Roles of Forkhead Box C1 in Pelvic EndometriosisF32HD104478 · NICHD · MICHIGAN STATE UNIVERSITY · PI BURNS, GREGORY WILLIS · 2021 to 2021
$66k
NICHD NIH HHS F32 HD104478NICHD NIH HHS R01 HD083273NICHD NIH HHS R01 HD099090NICHD NIH HHS R01 HD109152NICHD NIH HHS T32 HD087166
6 · The paper itself

Abstract

The development and progression of endometriotic lesions are poorly understood, but immune cell dysfunction and inflammation are closely associated with the pathophysiology of endometriosis. There is a need for 3D in vitro models to permit the study of interactions between cell types and the microenvironment. To address this, we developed endometriotic spheroids (ES) to explore the role of epithelial-stromal interactions and model peritoneal invasion associated with lesion development. Using a nonadherent microwell culture system, spheroids were generated with immortalized endometriotic epithelial cells (12Z) combined with endometriotic stromal (iEc-ESC) or uterine stromal (iHUF) cell lines. Transcriptomic analysis found 4,522 differentially expressed genes in ES compared with spheroids containing uterine stromal cells. The top increased gene sets were inflammation-related pathways, and an overlap with baboon endometriotic lesions was highly significant. Finally, to mimic invasion of endometrial tissue into the peritoneum, a model was developed with human peritoneal mesothelial cells in an extracellular matrix. Invasion was increased in the presence of estradiol or pro-inflammatory macrophages and suppressed by a progestin. Taken together, our results strongly support the concept that ES are an appropriate model for dissecting mechanisms that contribute to endometriotic lesion development.

Indexed as

EndometriosisCell LineEpithelial CellsEpitheliumFemaleGene Expression ProfilingHumansCell migration/adhesionReproductive Biology

Identifiers

PMID37104033
PMCPMC10393231
OpenAlexW4367174381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.